Every year, nearly 30 million Americans are diagnosed with a sinus infection, which can cause facial pain, headaches, congestion and other symptoms that often result in missed work or school.
Nearly 80-90% of the time, patients receive antibiotics to treat the infection, according to the Centers for Disease Control and Prevention. The problem, said Dr. Dan Merenstein, a professor in the School of Medicine and School of Health, is that there isn’t strong evidence behind this guidance.
“There is a debate: People need antibiotics or don’t need antibiotics. But it is not very well studied,” he said.
Merenstein and his team are changing that.
In the largest-of-its-kind study, Merenstein and co-investigator Nawar Shara of MedStar Health, are collaborating with investigators from six universities across the U.S. to determine the most effective treatment options for sinus infections.
Funded by a $23.6 million research grant from the Patient-Centered Outcomes Research Institute, Merenstein and his team are recruiting 3,700 participants across the U.S. to find out which patients need antibiotics and which can benefit from over-the-counter treatments or other interventions. And he’s inviting Georgetown students to help him.
Since January, undergraduates have fanned out to clinics across the metropolitan Washington area, helping recruit patients in downtown DC and across Maryland and Virginia.
Chiamaka Nwazue (H’26), a junior in the School of Health, is one such student. She began working on the study last year and contributed to the team’s work on their website. She’s seen the study through approvals and now helps recruit, onboard and track patients in clinics across DC, including Georgetown’s Student Health Center.